Pharma frustrated by Turkey's drug registration delays
This article was originally published in SRA
Executive Summary
Around 480 innovator pharmaceutical products, including new anticancers and diabetes drugs, are waiting to be registered in Turkey as the authorities try to find the resources to inspect some 260 manufacturing plants outside the country to meet a good manufacturing practice requirement that was introduced in December 2009.